Cross functional "excellence teams", a multichannel approach to reduce "information asymmetry" for customers, calibrating prices to improve access and penetrating deeper into middle and rural India are some of the core components of GlaxoSmithKline PLC’s ongoing effort to fundamentally overhaul its business in India.
"Given the new environment in India, we need to re-engineer the business model in a way that we are able to maintain margins but at the same time deliver value...